Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Each batch undergoes third-party testing at FDA- and DEA-registered labs
Tirzepatide is a dual-acting medication that belongs to a class known as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists
You tend to see a spike in sugar level in blood
Contact your healthcare provider if the diarrhea is severe or persistent
Storage conditions are governed by the trial sponsor's Pharmacy Manual, the IMP label, and UK Good Clinical Practice not a public SmPC
No increased cardiovascular risk was observed with tirzepatide in T2D participants versus controls
US$ 20.01
US$ 22.77
US$ 22.27
US$ 21.53
US$ 22.79
US$ 23.19
